PTC Therapeutics (PTCT) SEC Filings & 10K Form

$25.41
-0.56 (-2.16%)
(As of 04/23/2024 ET)

Recent PTC Therapeutics SEC Filings

DateFilerForm TypeView
04/22/2024
4:20 PM
Klein Matthew B. (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
4:20 PM
Klein Matthew B. (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
4:20 PM
Pauwels Eric (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
2:17 PM
Klein Matthew B. (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/17/2024
2:24 PM
Pauwels Eric (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/17/2024
2:13 PM
Klein Matthew B. (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/04/2024
4:16 PM
Golden Lee Scott (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
2:58 PM
Golden Lee Scott (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/29/2024
3:36 PM
PTC Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/16/2024
3:20 PM
PTC Therapeutics (Issuer)
SOUTHWELL DAVID P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:20 PM
Bell William F. Jr. (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:25 PM
PTC Therapeutics (Issuer)
SCHMERTZLER MICHAEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:10 PM
Boulding Mark Elliott (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:10 PM
Klein Matthew B. (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:10 PM
Golden Lee Scott (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:11 PM
Gravier Pierre (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:16 PM
Okey Stephanie (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
2:50 PM
ARMISTICE CAPITAL, LLC (Filed by)
PTC Therapeutics (Subject)
Form SC 13G
02/14/2024
6:13 AM
PTC Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G/A
02/08/2024
9:17 AM
PTC Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/30/2024
2:17 PM
PTC Therapeutics (Subject)
Utter Christine Marie (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/30/2024
2:18 PM
Almstead Neil Gregory (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/30/2024
2:18 PM
Almstead Zheng Yang (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/30/2024
2:25 PM
Pauwels Eric (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/24/2024
3:30 PM
Jacobson Allan Steven (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
12:11 PM
PTC Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/22/2024
3:11 PM
Jacobson Allan Steven (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/10/2024
3:06 PM
Golden Lee Scott (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
3:08 PM
Klein Matthew B. (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
3:09 PM
Pauwels Eric (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
3:10 PM
PTC Therapeutics (Issuer)
SCHMERTZLER MICHAEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
3:11 PM
PTC Therapeutics (Issuer)
Utter Christine Marie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
7:53 AM
FMR LLC (Filed by)
PTC Therapeutics (Subject)
Form SC 13G/A
01/09/2024
4:46 PM
Almstead Zheng Yang (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:35 PM
Klein Matthew B. (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:29 PM
Klein Matthew B. (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
3:30 PM
Golden Lee Scott (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:33 PM
Pauwels Eric (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:16 PM
Almstead Neil Gregory (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:17 PM
Boulding Mark Elliott (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:23 PM
PTC Therapeutics (Subject)
Utter Christine Marie (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
A new way to collect income from stocks (Ad)

Most people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively…

Click here to see me place one of these trades LIVE on camera.
01/08/2024
3:47 PM
Almstead Zheng Yang (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
3:35 PM
BlackRock Inc. (Filed by)
PTC Therapeutics (Subject)
Form SC 13G/A
01/08/2024
3:37 PM
Almstead Neil Gregory (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
3:46 PM
PTC Therapeutics (Subject)
Utter Christine Marie (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
3:29 PM
Boulding Mark Elliott (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
3:34 PM
Klein Matthew B. (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
3:35 PM
Golden Lee Scott (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
8:46 AM
PTC Therapeutics (Subject)
SCHMERTZLER MICHAEL (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
8:27 AM
PTC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2024
2:17 PM
Klein Matthew B. (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/28/2023
4:12 PM
Klein Matthew B. (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2023
3:38 PM
Gravier Pierre (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2023
8:02 AM
FMR LLC (Filed by)
PTC Therapeutics (Subject)
Form SC 13G/A
11/07/2023
3:16 PM
PTC Therapeutics (Filer)
Form POSASR
10/30/2023
8:05 AM
Camber Capital Management LP (Filed by)
PTC Therapeutics (Subject)
Form SC 13G
10/26/2023
3:34 PM
PTC Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/19/2023
3:15 PM
PTC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/19/2023
7:03 AM
PTC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/28/2023
3:45 PM
PTC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/22/2023
8:00 AM
PTC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/15/2023
5:15 AM
PTC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/03/2023
3:34 PM
PTC Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/19/2023
11:00 AM
PTC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2023
3:46 PM
PTC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2023
3:49 PM
Gravier Pierre (Reporting)
PTC Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/17/2023
3:51 PM
Gravier Pierre (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2023
6:30 AM
PTC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2023
3:41 PM
ClearPoint Neuro, Inc. (Subject)
ClearPoint Neuro, Inc. (Subject)
PTC Therapeutics (Filed by)
Form SC 13D/A
06/13/2023
3:26 PM
Golden Lee Scott (Reporting)
PTC Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/07/2023
10:49 AM
PTC Therapeutics (Subject)
SCHMERTZLER MICHAEL (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/05/2023
7:23 AM
ClearPoint Neuro, Inc. (Subject)
ClearPoint Neuro, Inc. (Subject)
PTC Therapeutics (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/24/2023
3:12 PM
PTC Therapeutics (Issuer)
Reeve Emma (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2023
4:36 PM
PTC Therapeutics (Subject)
Reeve Emma (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/23/2023
4:17 PM
PTC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2023
3:05 PM
Pauwels Eric (Reporting)
PTC Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2023
4:14 PM
PTC Therapeutics (Subject)
Reeve Emma (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/22/2023
4:24 PM
Pauwels Eric (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/19/2023
3:43 PM
Pauwels Eric (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/18/2023
3:37 PM
Pauwels Eric (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/17/2023
4:39 PM
Pauwels Eric (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/17/2023
6:04 AM
PTC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2023
11:40 AM
Jacobson Allan Steven (Reporting)
PTC Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/08/2023
9:31 AM
PTC Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
05/05/2023
3:31 PM
PTC Therapeutics (Filer)
Form S-3ASR
04/26/2023
7:32 AM
PTC Therapeutics (Filer)
Form ARS
04/26/2023
7:22 AM
PTC Therapeutics (Filer)
Form DEF 14A
04/26/2023
7:24 AM
PTC Therapeutics (Filer)
Form DEFA14A
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:PTCT) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners